Literature DB >> 20818728

The role of mitochondrial dysfunction in psychiatric disease.

Fernando Scaglia1.   

Abstract

Mitochondrial respiratory chain disorders are a group of genetically and clinically heterogeneous disorders caused by the biochemical complexity of mitochondrial respiration and the fact that two genomes, one mitochondrial and one nuclear, encode the components of the respiratory chain. These disorders can manifest at birth or present later in life. They result, at least in part, in defective production of ATP. Typically, mitochondrial disorders affect tissues with high energetic demands such as skeletal muscle, cardiac muscle, and the central nervous system. Neurological dysfunction is the most frequent clinical presentation of these disorders. The central nervous system is highly dependent on oxidative metabolism, and particular mitochondrial disorders are accompanied by focal brain necrosis (Leigh disease), dementia, or static encephalopathy. Furthermore, many children with mitochondrial encephalomyopathies present with more subtle and indolent signs including focal cognitive deficits of memory, perception, and language. Some subjects with mitochondrial disorders may also exhibit nonverbal cognitive impairment, compromised visuospatial abilities, and short-term memory deficits associated with working memory that likely reflect defects in synaptic plasticity. Psychiatric features are found within the clinical spectrum of mitochondrial syndromes. It is increasingly recognized that mitochondrial dysfunction may be associated with neuropsychiatric abnormalities such as dementia, major depression, and bipolar disorder. Furthermore, several lines of evidence suggest that there is involvement of mitochondrial dysfunction in schizophrenia, including documented alterations in brain energy metabolism, electron transport chain activity, and expression of genes involved in mitochondrial function. The purpose of this review article is to summarize the psychiatric features observed in mitochondrial cytopathies and discuss possible mechanisms of dysfunctional cellular energy metabolism that underlie the pathophysiology of major subsets of psychiatric disorders. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20818728     DOI: 10.1002/ddrr.115

Source DB:  PubMed          Journal:  Dev Disabil Res Rev        ISSN: 1940-5529


  39 in total

1.  Potentially diagnostic electron paramagnetic resonance spectra elucidate the underlying mechanism of mitochondrial dysfunction in the deoxyguanosine kinase deficient rat model of a genetic mitochondrial DNA depletion syndrome.

Authors:  Brian Bennett; Daniel Helbling; Hui Meng; Jason Jarzembowski; Aron M Geurts; Marisa W Friederich; Johan L K Van Hove; Michael W Lawlor; David P Dimmock
Journal:  Free Radic Biol Med       Date:  2016-01-08       Impact factor: 7.376

Review 2.  The case for the continuing use of the revised Cambridge Reference Sequence (rCRS) and the standardization of notation in human mitochondrial DNA studies.

Authors:  Hans-Jürgen Bandelt; Anita Kloss-Brandstätter; Martin B Richards; Yong-Gang Yao; Ian Logan
Journal:  J Hum Genet       Date:  2013-12-05       Impact factor: 3.172

3.  Inhibiting cytosolic translation and autophagy improves health in mitochondrial disease.

Authors:  Min Peng; Julian Ostrovsky; Young Joon Kwon; Erzsebet Polyak; Joseph Licata; Mai Tsukikawa; Eric Marty; Jeffrey Thomas; Carolyn A Felix; Rui Xiao; Zhe Zhang; David L Gasser; Yair Argon; Marni J Falk
Journal:  Hum Mol Genet       Date:  2015-06-03       Impact factor: 6.150

Review 4.  Integrating mitochondriomics in children's environmental health.

Authors:  Kelly J Brunst; Andrea A Baccarelli; Rosalind J Wright
Journal:  J Appl Toxicol       Date:  2015-06-05       Impact factor: 3.446

Review 5.  Assessing mitochondrial dysfunction in cells.

Authors:  Martin D Brand; David G Nicholls
Journal:  Biochem J       Date:  2011-04-15       Impact factor: 3.857

Review 6.  How to deal with oxygen radicals stemming from mitochondrial fatty acid oxidation.

Authors:  D Speijer; G R Manjeri; R Szklarczyk
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-07-05       Impact factor: 6.237

7.  Mitochondrial membrane potential is regulated by vimentin intermediate filaments.

Authors:  Ivan S Chernoivanenko; Elena A Matveeva; Vladimir I Gelfand; Robert D Goldman; Alexander A Minin
Journal:  FASEB J       Date:  2014-11-17       Impact factor: 5.191

8.  Oxygen Consumption Evaluation: An Important Indicator of Metabolic State, Cellular Function, and Cell Fate Along Neural Deregulation.

Authors:  Mariana Dutra Brito; Luiz Felipe Souza E Silva; Amanda Siena; Miruna Chipara; Sovan Sarkar; Tatiana Rosado Rosenstock
Journal:  Methods Mol Biol       Date:  2021

9.  Uncommon mutation in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS).

Authors:  Jasna David; Julie Omolola Okiro; Kevin Murphy; Marwa Elamin
Journal:  BMJ Case Rep       Date:  2017-02-27

Review 10.  Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-08-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.